Synlait Milk's (SML) 1H23 guidance for normalised NPAT to be below 1H22 (NZ$14.5m) appears to be a timing issue — it is not quite as the headline suggests; At ~13x 12m forward PE, SML is trading modestly below its five year average which we believe appropriately reflects the challenging backdrop, ongoing uncertainties, lower returns profile relative to history and changing mix in the business
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.